1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Polymerase Chain Reaction PCR
        1.2.3 Molecular Hybridization
        1.2.4 Biochip
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Infectious Diseases Molecular Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Third-party Testing Agency
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Infectious Diseases Molecular Diagnostics Market Perspective (2017-2028)
    2.2 Infectious Diseases Molecular Diagnostics Growth Trends by Region
        2.2.1 Infectious Diseases Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Infectious Diseases Molecular Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Infectious Diseases Molecular Diagnostics Market Dynamics
        2.3.1 Infectious Diseases Molecular Diagnostics Industry Trends
        2.3.2 Infectious Diseases Molecular Diagnostics Market Drivers
        2.3.3 Infectious Diseases Molecular Diagnostics Market Challenges
        2.3.4 Infectious Diseases Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue
        3.1.1 Global Top Infectious Diseases Molecular Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Infectious Diseases Molecular Diagnostics Revenue
    3.4 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio
        3.4.1 Global Infectious Diseases Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Molecular Diagnostics Revenue in 2021
    3.5 Infectious Diseases Molecular Diagnostics Key Players Head office and Area Served
    3.6 Key Players Infectious Diseases Molecular Diagnostics Product Solution and Service
    3.7 Date of Enter into Infectious Diseases Molecular Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases Molecular Diagnostics Breakdown Data by Type
    4.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
5 Infectious Diseases Molecular Diagnostics Breakdown Data by Application
    5.1 Global Infectious Diseases Molecular Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
    6.2 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
    6.3 North America Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
    7.2 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
    7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
    9.2 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Infectious Diseases Molecular Diagnostics Introduction
        11.1.4 Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 Qiagen
        11.2.1 Qiagen Company Detail
        11.2.2 Qiagen Business Overview
        11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Introduction
        11.2.4 Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.2.5 Qiagen Recent Development
    11.3 Illumina
        11.3.1 Illumina Company Detail
        11.3.2 Illumina Business Overview
        11.3.3 Illumina Infectious Diseases Molecular Diagnostics Introduction
        11.3.4 Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.3.5 Illumina Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Detail
        11.4.2 Abbott Business Overview
        11.4.3 Abbott Infectious Diseases Molecular Diagnostics Introduction
        11.4.4 Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.4.5 Abbott Recent Development
    11.5 Hologic
        11.5.1 Hologic Company Detail
        11.5.2 Hologic Business Overview
        11.5.3 Hologic Infectious Diseases Molecular Diagnostics Introduction
        11.5.4 Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.5.5 Hologic Recent Development
    11.6 BioMerieux
        11.6.1 BioMerieux Company Detail
        11.6.2 BioMerieux Business Overview
        11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Introduction
        11.6.4 BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.6.5 BioMerieux Recent Development
    11.7 Danaher (Cepheid)
        11.7.1 Danaher (Cepheid) Company Detail
        11.7.2 Danaher (Cepheid) Business Overview
        11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Introduction
        11.7.4 Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.7.5 Danaher (Cepheid) Recent Development
    11.8 Myriad Genetics
        11.8.1 Myriad Genetics Company Detail
        11.8.2 Myriad Genetics Business Overview
        11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Introduction
        11.8.4 Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.8.5 Myriad Genetics Recent Development
    11.9 DAAN Gene
        11.9.1 DAAN Gene Company Detail
        11.9.2 DAAN Gene Business Overview
        11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Introduction
        11.9.4 DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.9.5 DAAN Gene Recent Development
    11.10 Agilent
        11.10.1 Agilent Company Detail
        11.10.2 Agilent Business Overview
        11.10.3 Agilent Infectious Diseases Molecular Diagnostics Introduction
        11.10.4 Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.10.5 Agilent Recent Development
    11.11 Genomic Health
        11.11.1 Genomic Health Company Detail
        11.11.2 Genomic Health Business Overview
        11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Introduction
        11.11.4 Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.11.5 Genomic Health Recent Development
    11.12 BD
        11.12.1 BD Company Detail
        11.12.2 BD Business Overview
        11.12.3 BD Infectious Diseases Molecular Diagnostics Introduction
        11.12.4 BD Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.12.5 BD Recent Development
    11.13 Foundation Medicine
        11.13.1 Foundation Medicine Company Detail
        11.13.2 Foundation Medicine Business Overview
        11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Introduction
        11.13.4 Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022)
        11.13.5 Foundation Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Infectious Diseases Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Polymerase Chain Reaction PCR
    Table 3. Key Players of Molecular Hybridization
    Table 4. Key Players of Biochip
    Table 5. Key Players of Other
    Table 6. Global Infectious Diseases Molecular Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Infectious Diseases Molecular Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Infectious Diseases Molecular Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Infectious Diseases Molecular Diagnostics Market Share by Region (2023-2028)
    Table 12. Infectious Diseases Molecular Diagnostics Market Trends
    Table 13. Infectious Diseases Molecular Diagnostics Market Drivers
    Table 14. Infectious Diseases Molecular Diagnostics Market Challenges
    Table 15. Infectious Diseases Molecular Diagnostics Market Restraints
    Table 16. Global Infectious Diseases Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Infectious Diseases Molecular Diagnostics Market Share by Players (2017-2022)
    Table 18. Global Top Infectious Diseases Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2021)
    Table 19. Ranking of Global Top Infectious Diseases Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Infectious Diseases Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Infectious Diseases Molecular Diagnostics Product Solution and Service
    Table 23. Date of Enter into Infectious Diseases Molecular Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Infectious Diseases Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Infectious Diseases Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Application (2017-2022)
    Table 31. Global Infectious Diseases Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Infectious Diseases Molecular Diagnostics Revenue Market Share by Application (2023-2028)
    Table 33. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Roche Company Detail
    Table 44. Roche Business Overview
    Table 45. Roche Infectious Diseases Molecular Diagnostics Product
    Table 46. Roche Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 47. Roche Recent Development
    Table 48. Qiagen Company Detail
    Table 49. Qiagen Business Overview
    Table 50. Qiagen Infectious Diseases Molecular Diagnostics Product
    Table 51. Qiagen Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 52. Qiagen Recent Development
    Table 53. Illumina Company Detail
    Table 54. Illumina Business Overview
    Table 55. Illumina Infectious Diseases Molecular Diagnostics Product
    Table 56. Illumina Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 57. Illumina Recent Development
    Table 58. Abbott Company Detail
    Table 59. Abbott Business Overview
    Table 60. Abbott Infectious Diseases Molecular Diagnostics Product
    Table 61. Abbott Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 62. Abbott Recent Development
    Table 63. Hologic Company Detail
    Table 64. Hologic Business Overview
    Table 65. Hologic Infectious Diseases Molecular Diagnostics Product
    Table 66. Hologic Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Hologic Recent Development
    Table 68. BioMerieux Company Detail
    Table 69. BioMerieux Business Overview
    Table 70. BioMerieux Infectious Diseases Molecular Diagnostics Product
    Table 71. BioMerieux Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. BioMerieux Recent Development
    Table 73. Danaher (Cepheid) Company Detail
    Table 74. Danaher (Cepheid) Business Overview
    Table 75. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product
    Table 76. Danaher (Cepheid) Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Danaher (Cepheid) Recent Development
    Table 78. Myriad Genetics Company Detail
    Table 79. Myriad Genetics Business Overview
    Table 80. Myriad Genetics Infectious Diseases Molecular Diagnostics Product
    Table 81. Myriad Genetics Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. Myriad Genetics Recent Development
    Table 83. DAAN Gene Company Detail
    Table 84. DAAN Gene Business Overview
    Table 85. DAAN Gene Infectious Diseases Molecular Diagnostics Product
    Table 86. DAAN Gene Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. DAAN Gene Recent Development
    Table 88. Agilent Company Detail
    Table 89. Agilent Business Overview
    Table 90. Agilent Infectious Diseases Molecular Diagnostics Product
    Table 91. Agilent Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Agilent Recent Development
    Table 93. Genomic Health Company Detail
    Table 94. Genomic Health Business Overview
    Table 95. Genomic Health Infectious Diseases Molecular DiagnosticsProduct
    Table 96. Genomic Health Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. Genomic Health Recent Development
    Table 98. BD Company Detail
    Table 99. BD Business Overview
    Table 100. BD Infectious Diseases Molecular DiagnosticsProduct
    Table 101. BD Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 102. BD Recent Development
    Table 103. Foundation Medicine Company Detail
    Table 104. Foundation Medicine Business Overview
    Table 105. Foundation Medicine Infectious Diseases Molecular DiagnosticsProduct
    Table 106. Foundation Medicine Revenue in Infectious Diseases Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 107. Foundation Medicine Recent Development
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Diseases Molecular Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Polymerase Chain Reaction PCR Features
    Figure 3. Molecular Hybridization Features
    Figure 4. Biochip Features
    Figure 5. Other Features
    Figure 6. Global Infectious Diseases Molecular Diagnostics Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Third-party Testing Agency Case Studies
    Figure 9. Other Case Studies
    Figure 10. Infectious Diseases Molecular Diagnostics Report Years Considered
    Figure 11. Global Infectious Diseases Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Infectious Diseases Molecular Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Infectious Diseases Molecular Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Infectious Diseases Molecular Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Infectious Diseases Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2021
    Figure 17. North America Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Infectious Diseases Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 19. United States Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Infectious Diseases Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 23. Germany Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Infectious Diseases Molecular Diagnostics Market Share by Region (2017-2028)
    Figure 31. China Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Infectious Diseases Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 39. Mexico Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Infectious Diseases Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 43. Turkey Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Roche Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 46. Qiagen Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 47. Illumina Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 48. Abbott Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 49. Hologic Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 50. BioMerieux Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 51. Danaher (Cepheid) Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 52. Myriad Genetics Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 53. DAAN Gene Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 54. Agilent Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 55. Genomic Health Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 56. BD Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 57. Foundation Medicine Revenue Growth Rate in Infectious Diseases Molecular Diagnostics Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed